The aim is to evaluate the efficacy of Mirror Therapy on pain reduction and hand function in subjects with unilateral upper extremity Complex Regional Pain Syndrome Type I.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Pain perception
Timeframe: Recordings performed every day from day 0 to day 42 (Group A) and from day 0 to day 84 (Group B); Follow-up on day 72 (Group A) and day 114 (Group B).
Active Range of Motion
Timeframe: On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Strength
Timeframe: On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Dexterity
Timeframe: On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Volume of hand and forearm
Timeframe: On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Temperature
Timeframe: On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Health-related Quality of Life
Timeframe: On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)